Lineage Cell Correlations
| LCTX Stock | ILA 227.90 37.50 14.13% |
The current 90-days correlation between Lineage Cell Therape and Ram On Investments and is -0.22 (i.e., Very good diversification). The correlation of Lineage Cell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Lineage Cell Correlation With Market
Average diversification
The correlation between Lineage Cell Therapeutics, and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lineage Cell Therapeutics, and DJI in the same portfolio, assuming nothing else is changed.
Lineage |
The ability to find closely correlated positions to Lineage Cell could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lineage Cell when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lineage Cell - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lineage Cell Therapeutics, to buy it.
Moving against Lineage Stock
| 0.54 | MTDS | Meitav Dash Investments | PairCorr |
| 0.51 | ESLT | Elbit Systems | PairCorr |
| 0.45 | LUMI | Bank Leumi Le Earnings Call This Week | PairCorr |
| 0.41 | DSCT | Israel Discount Bank | PairCorr |
| 0.4 | RATI | Ratio Oil Explorations Earnings Call This Week | PairCorr |
| 0.37 | AZRG | Azrieli Group | PairCorr |
| 0.37 | JBNK | Jerusalem | PairCorr |
| 0.36 | GOLD | Gold Bond | PairCorr |
| 0.36 | MZTF | Mizrahi Tefahot Earnings Call Tomorrow | PairCorr |
| 0.34 | DLEKG | Delek Group | PairCorr |
| 0.32 | DISI | Discount Investment Corp | PairCorr |
| 0.31 | FIBI | First International Bank | PairCorr |
Related Correlations Analysis
| 0.28 | 0.5 | 0.95 | 0.76 | 0.83 | 0.89 | BEZQ | ||
| 0.28 | 0.57 | 0.43 | 0.67 | 0.44 | 0.12 | TUZA | ||
| 0.5 | 0.57 | 0.69 | 0.72 | 0.78 | 0.45 | RTLS | ||
| 0.95 | 0.43 | 0.69 | 0.85 | 0.91 | 0.86 | MORE-S8 | ||
| 0.76 | 0.67 | 0.72 | 0.85 | 0.74 | 0.59 | ELWS | ||
| 0.83 | 0.44 | 0.78 | 0.91 | 0.74 | 0.81 | MTAV | ||
| 0.89 | 0.12 | 0.45 | 0.86 | 0.59 | 0.81 | RMN | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Lineage Stock performing well and Lineage Cell Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lineage Cell's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BEZQ | 1.29 | 0.32 | 0.12 | (1.89) | 1.29 | 3.25 | 7.89 | |||
| TUZA | 2.77 | 0.02 | 0.00 | 0.15 | 4.23 | 5.77 | 20.66 | |||
| RTLS | 1.95 | 0.18 | 0.02 | 1.68 | 2.69 | 3.90 | 12.70 | |||
| MORE-S8 | 1.01 | 0.22 | 0.06 | (2.29) | 1.24 | 2.41 | 4.87 | |||
| ELWS | 3.30 | 0.21 | 0.03 | 0.68 | 4.37 | 7.68 | 23.26 | |||
| MTAV | 1.58 | 0.57 | 0.22 | (2.63) | 1.39 | 3.71 | 8.21 | |||
| RMN | 1.42 | 0.29 | 0.10 | 131.43 | 1.36 | 3.23 | 9.04 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lineage Cell without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Lineage Cell Corporate Management
Elected by the shareholders, the Lineage Cell's board of directors comprises two types of representatives: Lineage Cell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lineage. The board's role is to monitor Lineage Cell's management team and ensure that shareholders' interests are well served. Lineage Cell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lineage Cell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Mulroy | Independent Director | Profile | |
| Alfred Kingsley | Chairman of the Board, Director | Profile | |
| Gary Hogge | Senior Vice President of Clinical & Medical Affairs | Profile | |
| Alexandra Hernandez | Senior Director of Finance, Controller, Interim Principal Accounting Officer | Profile | |
| Deborah Andrews | Independent Director | Profile |